10x Genomics Bruttomarge
Was ist das Bruttomarge von 10x Genomics?
Bruttomarge von 10x Genomics, Inc. ist 66.15%
Was ist die Definition von Bruttomarge?
Die Bruttomarge ist die Differenz zwischen Umsatz und Kosten der verkauften Waren, dividiert durch den Umsatz und in Prozent ausgedrückt.
Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.
Bruttomarge von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu 10x Genomics
Was macht 10x Genomics?
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Unternehmen mit bruttomarge ähnlich 10x Genomics
- Shilpa Medicare hat Bruttomarge von 66.08%
- Vocera Communication Inc hat Bruttomarge von 66.08%
- SPS Commerce hat Bruttomarge von 66.09%
- First Property plc hat Bruttomarge von 66.13%
- Solutions 30 SE hat Bruttomarge von 66.14%
- Australian Ethical Investment Ltd hat Bruttomarge von 66.14%
- 10x Genomics hat Bruttomarge von 66.15%
- Western Areas hat Bruttomarge von 66.16%
- RPG Life Sciences hat Bruttomarge von 66.17%
- Chugai Pharmaceutical Co hat Bruttomarge von 66.18%
- Presidio Property Trust hat Bruttomarge von 66.19%
- Dragontail Systems hat Bruttomarge von 66.21%
- Wishpond Technologies hat Bruttomarge von 66.21%